corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 34 of 144 pages ‹ First  < 32 33 34 35 36 >  Last ›

HSL13422
Editorial .
Overpromoted Cholesterol Drugs
New York Times 2008 Apr 2
http://www.nytimes.com/2008/04/02/opinion/02wed2.html?em&ex=1207281600&en=6a736e1c560a66ba&ei=5070

HSL13423
Teinowitz I.
Congress Moves Closer to Tobacco Clampdown
Advertising Age 2008 Apr 2
http://adage.com/article?article_id=126123

HSL13452
Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects
PRNewswire-USNewswire 2008 Apr 2
http://pharmalive.com/news/index.cfm?articleID=528021&categoryid=43&newsletter=1

HSL13464
Grassley C.
Pharma Payments to Doctors (Floor Statement of U.S. Senator Chuck Grassley of Iowa)
United States Senate Committee on Finance 2008 Apr 2
http://finance.senate.gov/press/Gpress/2008/prg040208b.pdf

HSL13390
Baar A.
Vytorin Study May Add Weight To Debate On DTC Advertising
Marketing Daily 2008 Apr 1
http://publications.mediapost.com/index.cfm?fuseaction=Articles.san&s=79614&Nid=41031&p=448587

HSL13409
Bodoni S.
Glaxo Greek Drug Trade Cuts Unlawful, Court Aide Says
Bloomberg News 2008 Apr 1
http://www.bloomberg.com/apps/news?pid=20601202&sid=aGvJ5u.YLTNM&refer=healthcare

HSL13410
Ryan S.
Psychiatrists back sponsorship deals
The Australian 2008 Apr 1
http://www.theaustralian.news.com.au/story/0,25197,23463973-23289,00.html

HSL13418
Berenson A.
Accusations of Delays in Releasing Drug Results
New York Times 2008 Apr 1
http://www.nytimes.com/2008/04/01/business/01drug.html?_r=1&oref=slogin

HSL13426
Johnson LA.
Congress: Vytorin makers held bad news
Associated Press 2008 Apr 1
http://news.yahoo.com/s/ap/20080401/ap_on_bi_ge/vytorin_study_fallout

HSL13432
Heavey S.
U.S. lawmakers seek J&J, Amgen anemia drug records
Reuters 2008 Apr 1
http://www.reuters.com/article/marketsNews/idUKN0130607820080401?rpc=44

HSL13096
Light DW.
Reply to DiMasi, Hansen, and Grabowski.
J Health Polit Policy Law 2008 Apr; 33:(2):325-7
http://jhppl.dukejournals.org/cgi/reprint/33/2/325?view=long&pmid=18325905

HSL13238
Jetter A.
Strong Medicine: What's Ailing the FDA?
Reader's Digest 2008 Apr
http://www.rd.com/national-interest/special-reports-and-surveys/problems-in-the-fda/article.html

HSL13239
Samuel N.
One Drug, Many Tragedies
Reader's Digest 2008 Apr
http://www.rd.com/national-interest/consumer-safety/fda-approves-harmful-antibiotic/article.html

HSL13441
Cross J.
DxS Ltd.
Pharmacogenomics 2008 Apr; 9:(4):463-7
http://www.futuremedicine.com/doi/abs/10.2217/14622416.9.4.463

HSL13498
Editorial .
A double-edged sword
Nature Reviews Drug Discovery 2008 Apr; 7:(4):275
http://www.nature.com/nrd/journal/v7/n4/index.html

HSL13502
Rieger HJ.
[Advertising with pictorial portrayal of people in professional clothing. Decision of the Federal Court from March, 1, 2007].
Dtsch Med Wochenschr. 2008 April; 133:(15):793
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1075649

HSL13537
Spielmans GI, Thielges SA, Dent AL, Greenberg RP.
The accuracy of psychiatric medication advertisements in medical journals.
J Nerv Ment Dis. 2008 Apr; 196:(4):267-73
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005053-200804000-00002

HSL13538
Matter A, Keller TH.
Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
Drug Discov Today. 2008 Apr; 13:(7-8):347-52
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T64-4S7KRB5-5&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a83f996c40d1400552c781b9a722674e

HSL13547
Sharfstein SS.
Big Pharma and American Psychiatry.
The Journal of Nervous and Mental Disease 2008 Apr; 196:(4):265
http://www.jonmd.com/pt/re/jnmd/toc.00005053-200804000-00000.htm;jsessionid=LNfKQzBhMQkthtGLDm6l6LWLG3R66gyFp4ZQGspLLSZj61T7KwyK!670793751!181195628!8091!-1

HSL13559
Waldinger MD, Schweitzer DH.
Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
Journal of Sexual Medicine 2008 Apr; 5:(4):966-97
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1743-6109.2008.00633.x

HSL13560
Goldstein I.
Regarding Waldinger and Schweitzer's
J Sex Med 2008 Apr; 5:(4):965
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1743-6109.2008.00808.x

HSL13582
Harris S.
Medical Schools Wrestle with Conflict of Interest Policies
AAMC Reporter (Association of American Medical Colleges) 2008 Apr
http://www.aamc.org/newsroom/reporter/april08/coi.htm

HSL13602
Alpert JS.
Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
Am J Med 2008 Apr; 121:(4):253-5
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(08)00053-3

HSL13684
Mennuti M.
Are doctors prepared for direct-to-consumer advertising of genetic tests?
Obstet Gynecol 2008 Apr; 111:(4):991,
http://www.greenjournal.org/cgi/content/full/111/4/991

HSL13714
Hagen B, Pijl-Zieber EM, Souveny K, Lacroix A.
Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry
Can Nurse. 2008 Apr; 104:(4):30-5
http://www.ncbi.nlm.nih.gov/pubmed/18488765

HSL13719
Alexander GC, Zhang J, Basu A.
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs.
Med Care 2008 Apr; 46:(4):394-402
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=L6BPtgm0GJD26nFB3pbwzpphQk92cVKhdpkpp2bcK8kV8k9GcR5P!62360543!181195629!8091!-1?an=00005650-200804000-00009

HSL13748
Niebyl JR.
The pharmaceutical industry: friend or foe?
Am J Obstet Gynecol 2008 Apr; 198:(4):435-9
http://linkinghub.elsevier.com/retrieve/pii/S0002-9378(07)02228-4

HSL13786
Doran E, Henry DA.
Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
J Public Health Policy 2008 Apr; 29:(1):106-20
http://www.palgrave-journals.com/jphp/journal/v29/n1/full/3200170a.html

HSL13797
Gniady JA.
Regulating direct-to-consumer genetic testing: protecting the consumer without quashing a medical revolution.
Fordham Law Rev. 2008 Apr; 76:(5):2429-75
http://www.ncbi.nlm.nih.gov/pubmed/18546580

HSL13798
Pouillot R, Bilong C, Boisier P, Ciss M, Moumouni A, Amani I, Nabeth P.
[Illicit drug trade on the markets of Yaounde (Cameroon) and Niamey (Niger): characteristics of salesmen and quality of drugs].
Bull Soc Pathol Exot. 2008 Apr; 101:(2):113-8
http://www.ncbi.nlm.nih.gov/pubmed/18543704

HSL13814
Schowalter JE.
How to manage conflicts of interest with industry?
Int Rev Psychiatry. 2008 Apr; 20:(2):127-33
http://www.informaworld.com/smpp/content~db=all?content=10.1080/09540260801887728

HSL13869
Egilman DS, Bohme SR.
IJOEH and the critique of bias.
Int J Occup Environ Health 2008 Apr-Jun; 14:(2):147-51
http://www.ncbi.nlm.nih.gov/pubmed/18507293

HSL13900
Shankar PR.
PharmedOut.
Singapore Med J 2008 Apr; 49:(4):363-5
http://smj.sma.org.sg/4904/4904le2.pdf

HSL13972
Bell H.
Thanks, but no thanks.
Minn Med 2008 Apr; 91:(4):26-30
http://www.minnesotamedicine.com/PastIssues/April2008/CoverStoryApril2008/tabid/2505/Default.aspx

HSL13974
Stout MM.
Reader feedback on commercialism in dentistry article.
J Calif Dent Assoc 2008 Apr; 36:(4):240
http://www.cda.org/page/Library/cda_member/pubs/journal/jour0408/letters.pdf

HSL13975
Hordiner P, Saroyan J.
Readers Voice Concerns Over Ad
J Calif Dent Assoc 2008 Apr; 36:(4):240
http://www.cda.org/page/Library/cda_member/pubs/journal/jour0408/letters.pdf

HSL14017
Robinson S, Delongeas JL, Donald E, Dreher D, Festag M, Kervyn S, Lampo A, Nahas K, Nogues V, Ockert D, Quinn K, Old S, Pickersgill N, Somers K, Stark C, Stei P, Waterson L, Chapman K.
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
Regul Toxicol Pharmacol 2008 Apr; 50:(3):345-52
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WPT-4R8WK2M-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=c02db5bf494f34c077a7211a843b1ffb

HSL14092
Davis JM, Chen N, Glick ID.
Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect.
Nature 2008 Apr; 33:(5):971-5
http://www.nature.com/npp/journal/v33/n5/abs/1301493a.html;jsessionid=BE818FCB52D4772A6DFEF88D444AAB6F

HSL14147
Aitken P.
The ABPI code of practice: controls on the promotion of prescription medicines.
Clin Med. 2008 Apr; 8:(2):128-9
http://www.ingentaconnect.com/content/rcop/cm/2008/00000008/00000002/art00003?token=00521b8599de289c3157b76504c48766c25533a2b6c5f7a254d316a332b25757d5c4f6d4e227a17dc6

HSL14185
Malhotra P.
The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.
Indian J Med Ethics. 2008 Apr-Jun; 5:(2):61-5
http://www.ncbi.nlm.nih.gov/pubmed/18624153

HSL14274
Davar M.
Whose pen is being used to write your prescriptions? Nominal gifts, conflicts of interest, and continuing medical education
J Leg Med. 2008 Apr-Jun; 29:(2):199-217.
http://www.informaworld.com/smpp/urlmapping?request=%2Fopenurl%3Fgenre%3Darticle%26doi%3D10%2E1080%2F01947640802080355%26magic%3Dpubmed%7C%7C1B69BA326FFE69C3F0A8F227DF8201D0&referer=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F18569441%3Fordinalpos%3D1%26itool%3DEntrezSystem2%2EPEntrez%2EPubmed%2EPubmed_ResultsPanel%2EPubmed_DefaultReportPanel%2EPubmed_RVDocSum

HSL14369
Liu Y, Doucette WR.
Does direct-to-consumer advertising affect patients' choice of pain medications?
Curr Pain Headache Rep. 2008 Apr; 12:(2):89-93
http://www.ncbi.nlm.nih.gov/pubmed/18474186

HSL14432
Caldeira TR, Neves ER, Perini E.
[Historical evolution of package inserts in Brazil].
Cad Saude Publica 2008 Apr; 24:(4):737-43
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0102-311X2008000400003&lng=en&nrm=iso&tlng=en

HSL14474
Light DW, Warburton RN.
Ethical Standards for Healthcare Journal Editors: A Case Report and Recommendations
Harvard Health Policy Review 2008 Spring; 9:(1):46-55
http://www.hhpr.org/currentissue/archives.php

HSL14518
de Wildt G, Khoon CC.
Patents or patients? Global access to pharmaceuticals and social justice
Med Confl Surviv. 2008 Apr; 24:(Suppl 1):S52-61
http://www.ncbi.nlm.nih.gov/pubmed/18771195

HSL16177
Naudy G.
Quand le mix bouscule la promotion
PHARMACEUTIQUES 2008 Apr; 62-3
http://www.pharmaceutiques.com/phq/mag/pdf/phq156_62_industrie.pdf

HSL16178
Cristofari J.
Médecins - labos: Bien cerner les relations
PHARMACEUTIQUES 2008 Apr; 68-9
http://www.pharmaceutiques.com/phq/mag/pdf/phq156_68_industrie.pdf

HSL13403
Verispan Reports: Physicians Prefer Merck’s ePromotion Activities
Business Wire 2008 Mar 31
http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20080331005103&newsLang=en

HSL13405
Moynihan R.
Pharmacists sign with Big Pharma to promote anti-fat drug
Crikey 2008 Mar 31
http://www.crikey.com.au/Politics/20080331-Pharmacists-sign-deal-with-Roche-to-promote-controversial-anti-fat-drug.html

HSL13408
Dixon K.
ANALYSIS-US may compare medical products; companies wary
Reuters 2008 Mar 31
http://www.forbes.com/reuters/feeds/reuters/2008/03/31/2008-03-31T193238Z_01_N31419471_RTRIDST_0_DRUGS-COMPARISONS-ANALYSIS.html

HSL13411
Tamura Y, Tatebayashi M, Takada M, Masuda K.
Medical guidelines seen ailing / Donations from drugmakers call impartiality of research into question
The Daily Yomiuri, The Yomiuri Shimbun 2008 Mar 31
http://www.yomiuri.co.jp/dy/national/20080331TDY03103.htmhttp://

HSL13419
Aldhous P.
US wasted billions on ineffective cholesterol drugs
New Scientist 2008 Mar 31
http://www.newscientist.com/channel/health/dn13557-us-wasted-billions-on-ineffective-cholesterol-drugs.html

HSL13427
House Committee Requests Documents Relating to ESAs
PharmaLive 2008 Mar 31
http://pharmalive.com/news/index.cfm?articleID=527575&categoryid=9&newsletter=1

HSL13440
Compagni A, Cavalli L, Jommi C.
Pharmaceutical companies and Italian Regional Governments: Managing relationships in an increasing institutional complexity.
Health Policy 2008 Mar 31; epub ahead of print
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(08)00057-2

HSL13387
McConville C.
Ex-drug salesman: We lured docs with gifts
Boston Herald 2008 Mar 30
http://www.bostonherald.com/business/healthcare/view.bg?articleid=1083794&srvc=home&position=rated

HSL13389
Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM.
Use of Ezetimibe in the United States and Canada
NEJM 2008 Mar 30; epub ahead of print
http://content.nejm.org/cgi/content/full/NEJMsa0801461v1

HSL13400
Taylor L.
French consumer report slams branded drug spending 'waste'
Pharma Times 2008 Mar 30
http://www.pharmatimes.com/WorldNews/article.aspx?id=13159&src=EWorldNews

HSL13404
McConnaughey J.
'Silent tort reform': Federal agencies are saying their rules pre-empt injury lawsuits
Associated Press 2008 Mar 30
http://www.startribune.com/17139741.html

HSL13396
Ramachandran R.
Vaccine worries
Frontline (India) 2008 Mar 29
http://www.frontlineonnet.com/stories/20080411250700400.htm

HSL13406
Richards T.
Purely medicinal?
BMJ 2008 Mar 29; 336:(7646):693
http://www.bmj.com/cgi/content/extract/336/7646/693

HSL13448
Stark L, Sandell C, Barrett K.
Do Free Gifts Dictate Your Medical Care?
ABC News (USA) 2008 Mar 29
http://abcnews.go.com/Health/Story?id=4489640&page=1

HSL13478
Delamothe T.
Of medicine and medicines
BMJ 2008 Mar 29; 336:(7646):0
http://www.bmj.com/cgi/content/full/336/7646/0

HSL13479
Cole A.
Drug industry anxious about scrapping price regulation scheme
BMJ 2008 Mar 29; 336:(7646):686
http://www.bmj.com/cgi/content/extract/336/7646/686-a

HSL13480
Mayor S.
Opening the lid on open access
BMJ 2008 Mar 29; 336:(7646):688
http://www.bmj.com/cgi/content/extract/336/7646/688

HSL13481
Dyer O.
GP advised patients to take pills made by company she worked for
BMJ 2008 Mar 29; 336:(7646):689
http://www.bmj.com/cgi/content/full/336/7646/689-e

HSL13482
Ferner RE, Beard K.
Over the counter medicines: proceed with caution
BMJ 2008 Mar 29; 336:(7646):694
http://www.bmj.com/cgi/content/full/336/7646/694

HSL13342
Gold X to ‘brand manage’ Xenical
Pharmacy Daily (Australia) - registration required 2008 Mar 28
http://www.pharmacydaily.com.au

HSL13343
Big pharma spent $31m on promos to doctors
ABC News (Australia) 2008 Mar 28
http://www.abc.net.au/news/stories/2008/03/28/2201751.htm?section=justin

HSL13344
Woodhead M.
Hospitality report released
6minutes (Australia) 2008 Mar 28
http://www.6minutes.com.au/articles/z1/view.asp?id=166307

HSL13356
Mark D.
Report exposes drug companies' lobbying expenses
ABC News (Australia) 2008 Mar 28
http://www.abc.net.au/news/stories/2008/03/28/2201999.htm

HSL13357
Pharmas spend $31m on doctors: report
Associated Press 2008 Mar 28
http://news.smh.com.au/pharmas-spend-31m-on-doctors-report/20080328-2229.html

HSL13358
Barlow D.
Vermont spent millions on suspect drug Zyprexa
The Barre Montpelier Times Argus 2008 Mar 28
http://www.timesargus.com/apps/pbcs.dll/article?AID=/20080328/NEWS01/803280370/1002/NEWS01

HSL13364
Johnson LA.
Wyeth cutting 1,200 US sales jobs
Associated Press 2008 Mar 28
http://www.businessweek.com/ap/financialnews/D8VMCUPO0.htm

HSL13451
Asomura Y.
Drugmakers Keen To Grow Hay Fever Drugs Into All-Season Offerings
Nikkei English News 2008 Mar 28
http://www.nni.nikkei.co.jp/FR/TNKS/Nni20080328D27HH601.htm

HSL13322
Carpenter D, Zucker EJ, Avorn J.
Drug-Review Deadlines and Safety Problems
NEJM 2008 Mar 27; 358:(13):1354-1361
http://content.nejm.org/cgi/content/abstract/358/13/1354

HSL13329
Cortez MF, Pettypiece S.
Merck, Schering-Plough Appeal to Doctors to Boost Vytorin Sales
Bloomberg News 2008 Mar 27
http://www.bloomberg.com/apps/news?pid=20601202&sid=a9Fmg_Q9eeX4&refer=healthcare

HSL13335
Taylor L.
EU drug info proposals 'driven by industry interests'
Pharma Times 2008 Mar 27
http://www.pharmatimes.com/WorldNews/article.aspx?id=13143&src=EWorldNews

HSL13337
Demer L.
State settles lawsuit over lack of warnings on dangerous drug
Anchorage Daily News 2008 Mar 27
http://www.adn.com/front/story/357247.html

HSL13338
Berenson A.
Alaska Suit Against Lilly Is Settled
New York Times 2008 Mar 27
http://www.nytimes.com/2008/03/27/business/27zyprexa.html?_r=1&hp&oref=slogin

HSL13339
King Gets Warning Letter Over Avinza Promotion
PharmaLive 2008 Mar 27
http://pharmalive.com/news/index.cfm?articleID=526338&categoryid=9&newsletter=1

HSL13341
Schmidt R, Jinks B.
Otsuka to Pay Fine to Resolve Abilify Marketing Probe
Bloomberg News 2008 Mar 27
http://www.bloomberg.com/apps/news?pid=20601101&sid=aV3nbARo08kE

HSL13355
Hacker G.
Pharmaceutical freebies for doctors aren’t free
The Register-Guard (Eugene, Oregon) 2008 Mar 27
http://www.registerguard.com/csp/cms/sites/dt.cms.support.viewStory.cls?cid=84260&sid=5&fid=1

HSL13359
BMS decision to stop producing a paediatric form of efavirenz angers associations
APM Health Europe 2008 Mar 27
http://www.apmhealtheurope.com/home.php

HSL13360
Goldstein J.
The Supreme Court and Alaska’s Zyprexa Case
The Wall Street Journal Health Blog 2008 Mar 27
http://blogs.wsj.com/health/2008/03/27/the-supreme-court-and-alaskas-zyprexa-case/?mod=WSJBlog?mod=yahoo_hs

HSL13361
Huckman M.
Big Pharma Power Shift: CFOs Have the Mojo Now
Seeking Alpha 2008 Mar 27
http://seekingalpha.com/article/70112-big-pharma-power-shift-cfos-have-the-mojo-now?source=feed

HSL13363
Big drug makers raising prices on their best-sellers
Associated Press 2008 Mar 27
http://www.newsobserver.com/business/story/1014593.html

HSL13388
Milligan L.
25 Shocking Facts About the Pharmaceutical Industry
Nursing Education Online Database 2008 Mar 27
http://noedb.org/library/features/25-shocking-facts-about-the-pharmaceutical-industry

HSL13393
Winstein KJ.
Late Drug Approval Linked To Safety Issues
The Wall Street Journal 2008 Mar 27D1
http://online.wsj.com/article/SB120656190873766273.html

HSL13298
Dunlevy S.
Doctors defy ban on drug gifts
The Daily Telegraph (Sydney) 2008 Mar 26
http://www.news.com.au/dailytelegraph/story/0,22049,23432249-5001021,00.html

HSL13313
Berenson A.
Lilly Settles Alaska Suit Over Zyprexa
New York Times 2008 Mar 26
http://www.nytimes.com/2008/03/26/business/26cnd-zyprexa.html?_r=1&hp&oref=slogin

HSL13314
Harris G.
Cigarette Company Paid for Lung Cancer Study
New York Times 2008 Mar 26
http://www.nytimes.com/2008/03/26/health/research/26lung.html?th&emc=th

HSL13315
Mahar M.
Amid Bad Publicity, Drug Company Uses Progressive Union to Peddle Its Products
AlterNet 2008 Mar 26
http://www.alternet.org/healthwellness/80411/?page=1

HSL13316
How to Hold Pharma-Free Meetings
AMSA/PharmedOut 2008 Mar 26
http://www.pharmedout.org/PharmaFreeMeetingTipsWeb.pdf

HSL13317
Canadian Prescription Drug Sales Experience Slowest Growth in a Decade With 6.3% Increase
Canada Newswire English 2008 Mar 26
http://www.newswire.ca/en/releases/archive/March2008/26/c7060.html?view=print

HSL13318
Pettypiece S.
Pfizer, Glaxo Raise Prices as Drug Growth Declines
Bloomberg News 2008 Mar 26
http://www.bloomberg.com/apps/news?pid=20601103&sid=aHq9.4jizbSQ&refer=us

HSL13320
Koroneos G.
Physician Gifting Crackdown
PharmExec.com 2008 Mar 26
http://pharmexec.findpharma.com/pharmexec/News/Physician-Gifting-Crackdown/ArticleStandard/Article/detail/505158?contextCategoryId=43753

HSL13321
Emery G.
Drugs approved on US deadline seen with more risk
Reuters 2008 Mar 26
http://www.guardian.co.uk/feedarticle?id=7413438

HSL13323
Silverman E.
Lawmaker Asks NJ AG To Probe Antipsychotics
Pharmalot 2008 Mar 26
http://www.pharmalot.com/2008/03/lawmaker-asks-nj-ag-to-probe-antipsychotics/

HSL13340
Park A.
Did Big Tobacco Taint a Cancer Study?
TIME 2008 Mar 26
http://www.time.com/time/health/article/0,8599,1725719,00.html

HSL13362
Blum J, Goldstein A.
FDA `May Fail' Without More Funds, Agency Chief Says
Bloomberg News 2008 Mar 26
http://www.bloomberg.com/apps/news?pid=20601202&sid=apIyQKC6SJ0k&refer=healthcare

Page 34 of 144 pages ‹ First  < 32 33 34 35 36 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963